Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients – Journal of Fungi
The post Review | Invasive respiratory fungal infections in COVID-19 critically ill patients. appeared first on Links Medicus.
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet Respiratory Medicine Commentary: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical Related: Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial […]
The post RCT | Tixagevimab-cilgavimab for treatment of patients hospitalized with COVID-19. appeared first on Links Medicus.
Imaging the acute respiratory distress syndrome: past, present and future – Intensive Care Medicine Commentary on Twitter Imaging #ARDS: past, present & future➡️ physiopathology➡️ management: PEEP/recruitment; inflation (& hyperinfation)➡️ effects of proning on ventilation/perfusion➡️ lung infammation➡️ #COVID19➡️ identifying complications➡️ prognostication& more!? https://t.co/tEp50muK8J pic.twitter.com/GlME1vTePh — Intensive Care Medicine (@yourICM) July 14, 2022
The post Review | Imaging the acute respiratory distress syndrome: past, present and future. appeared first on Links Medicus.
Anti‐IL‐5 therapies for asthma – Cochrane Library Summary: Mepolizumab, reslizumab or benralizumab for people already taking inhaled steroids and long-acting beta 2-agonists for their asthma – Cochrane Library
The post Systematic Review | Anti‐IL‐5 therapies for asthma. appeared first on Links Medicus.
What cardiologists should know about sleep – European Heart Journal (free for a limited period)
The post What cardiologists should know about sleep. appeared first on Links Medicus.
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association – Circulation
The post AHA Science Advisory | Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action. appeared first on Links Medicus.
Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis – The Lancet Respiratory Medicine (link to abstract – $ for full-text) Commentary on Twitter Home oxygen probably makes little or no difference to 3-year mortality in pts with #COPD and moderate hypoxaemia Systematic review & meta-analysis from Yves […]
The post M-A | Home oxygen for moderate hypoxemia in chronic obstructive pulmonary disease. appeared first on Links Medicus.
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3B, Randomized, Placebo-Controlled Study – American Journal of Respiratory and Critical Care Medicine (link to abstract – $ for full-text)
The post RCT | Efficacy and safety of Elexacaftor/Tezacaftor/Ivacaftor in children 6 through 11 years of age with cystic fibrosis heterozygous for F508del and a minimal function mutation. appeared first on Links Medicus.
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors – PLOS Medicine Related: Interpreting a lateral flow SARS-CoV-2 antigen test – The BMJ Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library
The post M-A | Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2. appeared first on Links Medicus.
New coronavirus mutant raises concerns in India and beyond – Associated Press
The post New coronavirus mutant (BA.2.75) raises concerns in India and beyond. appeared first on Links Medicus.